Cetirizine HCL Oral Solution 1 mg/mL recalled over manufacturing violations
- Recall date
- June 5, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- P & L Developments, LLC recalls Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL,…
- Recall number
- D-1407-2019
- FDA classification
- Class II
- Brand / firm
- P & L Developments, LLC
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL, 4 FL. oz. Bottle, Distributed by Dolgencorp, LLC, 100 mission ridge, Goodlettsville, TN 37072, NDC 55910-878-04, UPC 359726178051.
Get recall alerts
Free email alert whenever P & L Developments, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: P & L Developments, LLC